Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NASDAQ | Common Stock
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China.
Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma.
The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer.
The company was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 2, 24 | -0.36 Increased by +28.00% | -0.42 Increased by +14.29% |
| Feb 22, 24 | -0.45 Decreased by -25.00% | -0.52 Increased by +13.46% |
| Oct 26, 23 | -0.46 Decreased by -84.00% | -0.52 Increased by +11.54% |
| Jul 27, 23 | -0.54 Decreased by -134.78% | -0.50 Decreased by -8.00% |
| May 4, 23 | -0.50 Decreased by -1.15 K% | -0.32 Decreased by -56.25% |
| Feb 23, 23 | -0.36 Decreased by -44.00% | -0.30 Decreased by -20.00% |
| Oct 27, 22 | -0.25 Decreased by -92.31% | -0.26 Increased by +3.85% |
| Jul 28, 22 | -0.23 Decreased by -64.29% | -0.14 Decreased by -64.29% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 127.32 M Decreased by -2.81% | -49.48 M Decreased by -86.20% | Decreased by -38.87% Decreased by -91.58% |
| Jun 30, 23 | 126.05 M Decreased by -10.52% | -57.42 M Decreased by -139.16% | Decreased by -45.55% Decreased by -167.27% |
| Mar 31, 23 | 122.18 M Decreased by -11.17% | -53.06 M Decreased by -1.04 K% | Decreased by -43.43% Decreased by -1.19 K% |
| Dec 31, 22 | 128.43 M Decreased by -3.59% | -37.30 M Decreased by -40.99% | Decreased by -29.05% Decreased by -46.24% |
| Sep 30, 22 | 131.00 M Decreased by -1.95% | -26.58 M Decreased by -102.50% | Decreased by -20.29% Decreased by -106.53% |
| Jun 30, 22 | 140.87 M Increased by +5.50% | -24.01 M Decreased by -63.98% | Decreased by -17.04% Decreased by -55.42% |
| Mar 31, 22 | 137.55 M Increased by +2.12% | -4.65 M Decreased by -12.57% | Decreased by -3.38% Decreased by -10.24% |
| Dec 31, 21 | 133.21 M Decreased by -7.46% | -26.46 M Decreased by -638.09% | Decreased by -19.86% Decreased by -681.47% |